---
document_datetime: 2025-09-23 17:33:37
document_pages: 16
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/olanzapine-apotex-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: olanzapine-apotex-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 24.1985789
conversion_datetime: 2025-12-19 23:18:12.925793
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

| product   |
|-----------|

Medicinal product no longer authorised

2 A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g. summary of product characteristics, annexII, labelling,package leaflet).The CDisissuedwithintwomonthsof the opinionforvariationsfallingunderthescopeofArticle23.1a(a)ofRegulation(Eu)No.712/2012,orwithinoneyearforotherprocedures.

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

| Medicinal product no   |
|------------------------|

<div style=\"page-break-after: always\"></div>

| product no   |
|--------------|
| Medicinal    |

<div style=\"page-break-after: always\"></div>

|           |        | authorised   |
|-----------|--------|--------------|
|           | longer |              |
|           | no     |              |
| product   |        |              |
| Medicinal |        |              |

<div style=\"page-break-after: always\"></div>

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | product no longer   |
|-----------|---------------------|
| Medicinal |                     |

<div style=\"page-break-after: always\"></div>

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

| Medicinal product   | no longer authorised   |
|---------------------|------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

| Medicinal product no   |
|------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

| Medicinal product   | no longer authorised   |
|---------------------|------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           |           | authorised   |
|-----------|-----------|--------------|
| product   | no longer |              |
| Medicinal |           |              |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| Medicinal product no   |
|------------------------|

<div style=\"page-break-after: always\"></div>

| no longer authorised   |
|------------------------|

<!-- image -->